Company information & drug savings for Veloxis Pharmaceuticals, Inc. medications

Veloxis Pharmaceuticals is a specialty pharmaceutical company focused on transplant medicine. The company developed Envarsus XR (tacrolimus extended-release tablets), an immunosuppressant using MeltDose technology for kidney transplant rejection prevention. Veloxis’s transplant expertise improves medication adherence and outcomes for organ transplant recipients.